BACKGROUND AND PURPOSE: The aim of this study is to estimate the risk of ischemic stroke during a 3-year follow-up period after a tuberculosis diagnosis using a nationwide, population-based study and a retrospective cohort design. METHOD: The study cohort comprised 2283 patients who had received treatment for tuberculosis, except tuberculosis of the meninges and central nervous system, between 2000 and 2003; 6849 randomly selected subjects comprised the comparison cohort. Cox proportional hazard regressions were performed as a means of comparing the 3-year ischemic stroke-free survival rate between these 2 cohorts. RESULTS: Of the 9132 sampled patients, 392 (4.3%) experienced ischemic stroke during the 3-year follow-up period, including 136 (6.0% of the tuberculosis patients) from the study cohort and 256 (3.7%) from the comparison cohort. After adjusting for patient age, gender, hypertension, diabetes, coronary heart disease, hyperlipidemia, malignancy, monthly income, and the geographical region and urbanization level of the community in which the patient resided, the hazard ratio of ischemic stroke for tuberculosis patients was 1.52-times (95% CI, 1.21-1.91; P<0.001) higher than for comparison patients. CONCLUSIONS: We conclude that patients with a tuberculosis diagnosis are at an increased risk for ischemic stroke but not hemorrhagic stroke in the next 3 years. Further research is necessary to investigate these findings in tuberculosis-endemic areas.
BACKGROUND AND PURPOSE: The aim of this study is to estimate the risk of ischemic stroke during a 3-year follow-up period after a tuberculosis diagnosis using a nationwide, population-based study and a retrospective cohort design. METHOD: The study cohort comprised 2283 patients who had received treatment for tuberculosis, except tuberculosis of the meninges and central nervous system, between 2000 and 2003; 6849 randomly selected subjects comprised the comparison cohort. Cox proportional hazard regressions were performed as a means of comparing the 3-year ischemic stroke-free survival rate between these 2 cohorts. RESULTS: Of the 9132 sampled patients, 392 (4.3%) experienced ischemic stroke during the 3-year follow-up period, including 136 (6.0% of the tuberculosispatients) from the study cohort and 256 (3.7%) from the comparison cohort. After adjusting for patient age, gender, hypertension, diabetes, coronary heart disease, hyperlipidemia, malignancy, monthly income, and the geographical region and urbanization level of the community in which the patient resided, the hazard ratio of ischemic stroke for tuberculosispatients was 1.52-times (95% CI, 1.21-1.91; P<0.001) higher than for comparison patients. CONCLUSIONS: We conclude that patients with a tuberculosis diagnosis are at an increased risk for ischemic stroke but not hemorrhagic stroke in the next 3 years. Further research is necessary to investigate these findings in tuberculosis-endemic areas.
Authors: G PrayGod; N Range; D Faurholt-Jepsen; K Jeremiah; M Faurholt-Jepsen; M G Aabye; P Magnussen; J Changalucha; A B Andersen; J C K Wells; H Friis Journal: Eur J Clin Nutr Date: 2015-04-01 Impact factor: 4.016
Authors: F Gerry R Fowkes; Victor Aboyans; Freya J I Fowkes; Mary M McDermott; Uchechukwu K A Sampson; Michael H Criqui Journal: Nat Rev Cardiol Date: 2016-11-17 Impact factor: 32.419
Authors: Moises A Huaman; Eduardo Ticona; Gustavo Miranda; Richard J Kryscio; Raquel Mugruza; Ernesto Aranda; Paola L Rondan; David Henson; Cesar Ticona; Timothy R Sterling; Carl J Fichtenbaum; Beth A Garvy Journal: Clin Infect Dis Date: 2018-03-05 Impact factor: 9.079
Authors: M A Huaman; R J Kryscio; C J Fichtenbaum; D Henson; E Salt; T R Sterling; B A Garvy Journal: Epidemiol Infect Date: 2017-02-16 Impact factor: 2.451
Authors: M J Magee; A D Salindri; U P Gujral; S C Auld; J Bao; J S Haw; H-H Lin; H Kornfeld Journal: Int J Tuberc Lung Dis Date: 2018-11-01 Impact factor: 2.373
Authors: Moises A Huaman; Carlo N De Cecco; Marcio S Bittencourt; Eduardo Ticona; Cissy Kityo; Isabel Ballena; Sophie Nalukwago; Rashidah Nazzinda; Cesar Ticona; Ruben Azañero; Bin Zhang; Carey Farquhar; Thomas R Hawn; Timothy R Sterling; Carl J Fichtenbaum; Chris T Longenecker Journal: Clin Infect Dis Date: 2021-11-02 Impact factor: 9.079